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344 The Journal of Thoracic and Cardbjective: Many studies of neurodevelopmental outcomes after neonatal and infant
ardiac surgery have focused on potentially modifiable risk factors for adverse
utcomes, primarily intraoperative management strategies and the use of deep
ypothermic circulatory arrest. There is increasing evidence that patient-specific
actors are more important determinants of outcome.
ethods: We investigated predictors of neurodevelopmental outcomes at 1 year of
ge after neonatal and infant cardiac surgery in a subgroup of infants enrolled in a
rospective study of apolipoprotein E (APOE) genotype and neurodevelopmental
utcome. Children with a variety of 2-ventricle cardiac defects repaired with only 1
peration with cardiopulmonary bypass and no more than 1 episode of deep
ypothermic circulatory arrest were included. Neurodevelopmental outcomes at 1
ear of age included the Bayley Scales of Infant Development-II, which yield 2
ndices, the Mental Developmental Index and the Psychomotor Developmental
ndex.
esults: Two hundred forty-seven infants underwent surgical repair between Octo-
er 1998 and April 2003 with 1 hospital death and 3 deaths before 1 year of age.
eurodevelopmental evaluation was performed in 188 (77%) of 243 survivors,
ncluding 56 patients with tetralogy of Fallot, 39 with transposition of the great
rteries with intact ventricular septum, 34 with ventricular septal defects, and 59
ith other defects. The median age at operation was 56 days (1–186 days), including
2 (38%) neonates. Confirmed or suspected genetic syndromes were present in 59
31%) of 188 infants. Deep hypothermic circulatory arrest was used in 67 (35%)
nfants with a median duration of 34 minutes (1-80 minutes). For the entire cohort,
he mean Mental Developmental Index was 90.6  14.9 and the mean Psychomotor
evelopmental Index was 81.6  17.2. For patients without genetic syndromes, the
ean Mental Developmental Index was 93.7  13.6 and the mean Psychomotor
evelopmental Index was 85.1  14.6. For the entire cohort, predictors of lower
cores for both the Mental Developmental Index and Psychomotor Developmental
ndex were presence of a confirmed or suspected genetic syndrome, lower birth
eight, and presence of the APOE 2 allele (all P .04). Black race was associated
ith higher scores on the Psychomotor Developmental Index (P  .018). Lower
asopharyngeal temperature during cardiopulmonary bypass was associated with a
ower score on the Psychomotor Developmental Index (P  .03) and was the only
ntraoperative factor that was a significant predictor of either the Mental or Psy-
homotor Developmental Index.
onclusions: The strongest predictors of a worse neurodevelopmental outcome at 1
ear of age were patient-specific factors including presence of a genetic syndrome,
ow birth weight, and presence of the APOE 2 allele. Patient-specific factors
clipsed the use and duration of deep hypothermic circulatory arrest as predictors of
orse neurodevelopmental outcomes.
iovascular Surgery ● May 2007
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Dhere has been increasing recognition of adverse neu-
rodevelopmental outcomes in some survivors of
neonatal and infant cardiac surgery. Many previous
bservational studies and neuroprotective trials have fo-
used on potentially modifiable risk factors, particularly
ntraoperative management strategies. The findings of these
tudies have led many institutions to alter their intraopera-
ive management strategies, particularly avoidance of deep
ypothermic circulatory arrest (DHCA). However, review of
hese studies suggests that factors other than intraoperative
anagement strategies may be more important determinants of
eurodevelopmental outcomes for many children. The Boston
irculatory Arrest Study (BCAS) provides the most compre-
ensive overview of neurodevelopmental outcomes after infant
ardiac surgery.1-4 In this study, infants undergoing the arte
witch procedure (1988–1992) for transposition of the great
rteries (TGA) with or without a ventricular septal defect
VSD) were prospectively randomized to an operative support
trategy of either primarily DHCA or primarily continuous
ow-flow cardiopulmonary bypass (CPB). At 8 years of age,
eurodevelopmental status for the cohort as a whole was
elow expectations for many domains, including academic
chievement, fine motor function, and higher-order lan-
uage skills, regardless of use of DHCA or low-flow C3
onger postoperative length of stay in the cardiac intensive
are unit at the time of the initial operation was an inde-
endent risk factor for lower IQ scores at 8 years.5 The lack
f a treatment group effect for many outcomes and the
nding that prolonged length of stay was associated with a
orse outcome at 8 years suggest that factors other than
ntraoperative management strategies may be important de-
erminants of neurodevelopment outcome.3
The current study was undertaken to evaluate the relative
ontributions of a variety of patient-specific factors (eg,
estational age, ethnicity, presence of a genetic syndrome),
s well as intraoperative management strategies, as predic-
ors of neurodevelopmental outcomes at 1 year of age after
eonatal and infant cardiac surgery. The study uses a sub-
roup of infants enrolled in a prospective study evaluating
polipoprotein E (APOE) genotype as a risk factor for
dverse neurodevelopmental outcomes after neonatal and
nfant cardiac surgery.6 To minimize the potential co-
ounding effects of chronic cyanosis and multiple opera-
ions, the current study evaluated children with a variety of
-ventricle congenital heart defects (CHD) undergoing
omplete repair with only one operation with CPB with or
ithout DHCA.
aterials and Methods
ample
his study constitutes a secondary analysis of a subgroup of
atients enrolled in a prospective trial assessing the effects of
olymorphisms of the APOE gene on neurodevelopmental out-
omes in patients 6 months of age or less undergoing surgical D
The Journal of Thoracicepair for CHD.6 Patients 6 months of age or less undergoing 
ith or without DHCA for repair of CHD were eligible. Exclusion
riteria included (1) multiple congenital anomalies, (2) recogniz-
ble genetic or phenotypic syndrome other than chromosome
2q11 microdeletions, and (3) language other than English spoken
n the home. The current study evaluated infants who underwent
epair of a variety of 2-ventricle cardiac defects with CPB with or
ithout DHCA. Patients undergoing more than one operation with
PB or more than one episode of DHCA were excluded. The study
as approved by the Institutional Review Board at The Children’s
ospital of Philadelphia. Informed consent was obtained from the
arent or guardian.
perative Management
urgery was performed by 5 cardiac surgeons with a dedicated
eam of cardiac anesthesiologists. Alpha-stat blood gas manage-
ent was used. Pump flow rates were not standardized for this
tudy. In general, during normothermic or mild hypothermic CPB
nasopharyngeal [NP] temperature  28°C), the pump flow rate
as maintained at 100 to 150 mL · kg1 · min1 to achieve a mean
rterial pressure of 30 to 55 mm Hg. When moderate hypothermia
NP temperature 22°C-28°C) was used, the pump flow rate was
aintained at 100 mL · kg1 · min1 with a target mean arterial
ressure greater than 30 mm Hg. For deep hypothermic continuous
PB (NP temperature  22°C), a pump flow rate of 25 to 50 mL ·
g1 · min1 was used. These were general guidelines that were
odified according to the clinical situation. DHCA was used at the
urgeon’s discretion. Before DHCA, patients underwent core cool-
ng, with topical hypothermia of the head, to an NP temperature of
8°C. Modified ultrafiltration was performed in all patients. Post-
peratively, patients were managed in the cardiac intensive care
nit by a dedicated team of cardiologists and intensivists.
ata Collection
reoperative factors including gestational age, birth head circum-
erence, birth weight, Apgar scores, and preoperative intubation
ere obtained from birth and hospital records. Weight, age at
peration, and type of operation were recorded along with perfu-
ion data, including CPB time, aortic crossclamp time, and dura-
ion of DHCA. Total support time was calculated as CPB time plus
Abbreviations and Acronyms
APOE  apolipoprotein E
BCAS  Boston Circulatory Arrest Study
CHD  congenital heart defect
CPB  cardiopulmonary bypass
DHCA deep hypothermic circulatory arrest
MDI Mental Developmental Index
NP  nasopharyngeal
PDI  Psychomotor Developmental Index
TGA  transposition of the great arteries
TOF  tetralogy of Fallot
VSD  ventricular septal defectCHA time.
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DPOE Genotype Determination
hole blood or a buccal swab was obtained before the operation
nd stored at 4°C. Genomic DNA was prepared and used to
etermine APOE genotypes using a previously published metho7
ne-year Neurodevelopmental Examination
hildren were scheduled for their 1-year follow-up visit as they
pproached 1 year of age. A 2-week window was established so
hat children were seen at 12 months  2 weeks. Children born
efore 37 weeks of gestation were seen at their corrected age. The
evelopmental assessment was performed first, followed by med-
cal history, physical, and neurologic examinations. The develop-
ental assessment included the Bayley Scales of Infant Develop-
ent-II, which yields scores on two indices: the Psychomotor
evelopment Index (PDI) and the Mental Developmental Index
MDI). The medical evaluation included interim health history and
hysical examination. The child’s ethnicity and the familial socio-
conomic status were assessed by parental report according to the
ollingshead scale.8 Ethnicity was classified as Asian/Pacific -
ander, black, Hispanic, American Indian, other, or white. Neuro-
uscular examination included neuromuscular tone, symmetry,
trength and skills, reflexes, and bulbar function. Children were
lassified as “normal” or “abnormal/suspect.” Growth measure-
ents included weight, length, and head circumference. Patients
ere also evaluated by a genetic dysmorphologist. Chromosomal
nalysis and testing for microdeletions of chromosome 22q11 were
erformed as indicated. Neonatal recognition of dysmorphic fea-
ures may be difficult; therefore, some patients were enrolled in
hom the diagnosis of a genetic syndrome was not made until the
-year evaluation. Patients were classified as having no definite
enetic syndrome or chromosomal abnormality (“normal”) or as
aving a definite or suspected genetic syndrome or chromosomal
bnormality (“abnormal/suspect”).
ata Analysis and Statistical Methods
ata are presented as either median (range) or mean  standard
eviation, as appropriate. All predictors listed in Table 1 
ested by linear regression for univariate prediction of MDI, PDI,
nd head circumference, and logistic regression for prediction of
euromuscular outcome (0  “normal,” 1  “abnormal/suspect”).
stimates for logistic regression models are given as log odds.
atients were classified according to their primary cardiac diagno-
is. The most common diagnoses were tetralogy of Fallot (TOF),
GA, and VSD. Patients with other defects were coded as “other.”
ubjects were grouped by APOE genotype into the 2 group (22
nd 32), the 3 group (33), and the 4 group (34 and 44).
he 24 subjects were excluded from the analyses because the 2
nd 4 alleles are opposing in their effects in some conditions, such
s Alzheimer disease. Categorical variables were coded as dummy
ariables, with the most common category as the reference group
nd the overall model P value used. For each outcome, all predic-
ors with a marginal P  .1 were considered in a separate forward
tepwise logistic regression to determine a model for prediction of
hat outcome. Stepwise model results are given for predictors with
values  .05. Explained variance for all models was calculated
y adjusted r2 values. Use of DHCA was also considered sepa-
ately from the quantitative variable duration of DHCA. All anal- m
346 The Journal of Thoracic and Cardiovascular Surgery ● Mases used SPSS 10.0 for Windows (SPSS, Inc, Chicago, Ill) and
he R statistical software environment.
esults
tudy Population
etween October 1998 and April 2003, 675 eligible neo-
ates and infants underwent cardiac surgery and 550 (81%)
nrolled in the APOE study. Of these 550 patients, 247 met
he criteria of 2-ventricle CHD repaired with only one
peration with CPB and no more then one episode of
HCA. There was 1 hospital death (0.4% mortality) with 3
dditional deaths before 1 year of age. One-hundred eighty-
ight (77%) of the 243 eligible patients returned and com-
leted the 1-year evaluation. Fifty-five patients were alive at
year but did not return for evaluation.
Preoperative and intraoperative characteristics were
ompared for the 188 patients who returned and the 55
atients who did not return (Table E1). There wer
ifferences in gender, ethnicity, APOE genotype, or cardiac
iagnosis between the groups. All patients who were the
roduct of a multiple gestation returned for 1-year evalua-
ion. There were differences in some intraoperative vari-
bles between the two groups (Table E1). Patients who
ot return were older at the time of operation and had
horter CPB and total support times. Among the patients
ndergoing continuous CPB, the lowest NP temperature
as less than 25°C in 37% of the patients and less then 20°C
n 19% of the patients. Use and duration of DHCA was not
ignificantly different between the two groups.
In the cohort of 188 patients who returned for 1-year
valuation, there were 85 female and 103 male patients. The
edian gestational age was 39 weeks (range, 28–42 weeks)
nd the median birth weight was 3175 g (range, 739–5140 g).
hirty-one (16%) patients were less than 37 weeks’ gesta-
ional age. Birth weight was less than 2250 g in 18 (10%)
atients. There were 4 patients of Asian/Pacific Island eth-
icity, 23 black patients, 6 Hispanic patients, 136 white
atients, and 19 of other ethnic origin. TOF was present in
6 patients, TGA with intact ventricular septum in 39 pa-
ients, VSD in 34, and a variety of other 2-ventricle cardiac
efects in the remaining 59 patients.
The median age at operation was 56 days (range, 1-186
ays). Surgical intervention was performed on 72 (38%)
atients as neonates (age  30 days). The median weight at
he time of operation was 3.9 kg (range, 1.7–7.7 kg), and 8
4%) patients were less than 2.25 kg at the time of the
peration. The median hematocrit after hemodilution on
ypass was 27% (range, 17%-39%) and was less than 25% in
6 patients. DHCA was used in 67 (36%) patients (Figu
hen DHCA was used, the median lowest NP temperature
as 18°C (range, 15°C–28°C). The median duration of cool-
ng for patients undergoing DHCA was 15 minutes (range,
–22 minutes). The median duration of DHCA was 34
inutes (range, 1–80 minutes). When DHCA was not used,
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Dhe median NP temperature was 26°C (range, 17°C–37° C).
he median duration of total support was 79 minutes (range,
4–242 minutes).
ne-year Neurodevelopmental Evaluation
or the entire cohort (n  188), the mean MDI was 90.6 
4.9 and the mean PDI was 81.6  17.2. For patients
ithout genetic syndromes (n  129), the mean MDI was
3.7  13.6 and the mean PDI was 85.1  14.6. In the
eneral population, mean MDI and PDI scores are 100 with
normal distribution. In this cohort, the distributions of
cores for both the MDI and PDI are shifted leftward
ABLE 1. Single covariate analysis
n
MDI
 SE
reoperative covariates
Gender 188 1.936 2.184
Ethnicity (ref: white) 188
Socioeconomic status 188 1.591 0.991
Gestational age (wk) 188 1.472 0.434
Multiple gestation (Y/N) 187 13.362 4.757
Delivery (cesarean section vs vaginal) 186 3.450 2.366
Apgar at 1 min 184 0.968 0.659
Apgar at 5 min 184 1.560 1.152
Confirmed or suspected genetic
syndrome
188 9.681 2.226
APOE 2 genotype (ref: 33) 186
Weight at birth (gm) 187 0.007 0.002
Head circumference at birth (cm) 183 1.397 0.492
Prostaglandin infusion (Y/N) 186 3.384 2.450
Preoperative intubation (Y/N) 186 3.188 2.554
Cardiac diagnosis (ref: TOF) 188
Preoperative length of stay (d) 188 0.364 0.220
perative covariates
Age at operation (d) 188 0.002 0.020
Weight at operation (kg) 188 1.740 0.797
Surgeon (ref: 3) 188
Total support time [CPB  DHCA] (min) 188 0.001 0.025
CPB time (min) 188 0.017 0.023 0
DHCA time (min) 188 0.117 0.060
DHCA (Y/N) 188 5.206 2.242
Hematocrit after hemodilution (%) 188 0.249 0.263
Cooling time (min) 188 0.134 0.179
Lowest NP temperature (°C) 188 0.234 0.205
Delayed sternal closure (Y/N) 188 6.650 4.266
ECMO (Y/N) 188 7.000 10.605
Postoperative length of stay (d) 188 0.286 0.100
Total length of stay (d) 188 0.247 0.082
or each outcome, single covariates with P  0.1 are shown in boldface. A
HCA, deep hypothermic circulatory arrest; ECMO, extracorporeal membr
sychomotor developmental index; SE, standard error; TGA/IVS, transposit
SD, ventricular septal defect; Y/N, yes/no.Figure 2). The PDI is more severely affected than the MDa
The Journal of Thoraciche MDI was 70 or less (2 standard deviations below the
ean) in 17 (9%) patients and the PDI was 70 or less in 42
22%) patients. Potential predictors of the MDI and PDI are
isted in Table 1, as well as their univariate stati
ignificance. Stepwise logistic regression for MDI identified
model containing lower birth weight, presence of a con-
rmed or suspected genetic syndrome, and presence of the
POE 2 allele as significant predictors a lower MDI score
Table 2). For the PDI, stepwise logistic regression id
ed a model containing lower birth weight, presence of a
onfirmed or suspected genetic syndrome, the APOE 2
PDI
Neuromuscular
examination Head circumference
 SE P  SE P  SE P
0.348 2.533 .891 0.034 0.336 .920 1.281 0.236 .000
.056 .092 .145
0.155 1.155 .894 0.136 0.149 .361 0.226 0.115 .050
1.455 0.507 .005 0.177 0.066 .007 0.095 0.051 .068
9.124 5.590 .104 0.701 0.669 .295 0.099 0.562 .860
4.628 2.716 .090 0.465 0.355 .190 0.492 0.273 .073
2.031 0.754 .008 0.334 0.102 .001 0.111 0.077 .152
3.238 1.321 .015 0.488 0.195 .012 0.240 0.134 .075
11.099 2.579 .000 1.553 0.355 .000 0.437 0.269 .106
.014 .092 .278
0.006 0.002 .001 0.001 0.000 .001 0.001 0.000 .000
1.259 0.583 .032 0.196 0.078 .012 0.410 0.050 .000
2.009 2.851 .482 0.474 0.401 .238 0.036 0.285 .899
4.479 2.955 .131 0.129 0.075 .087 0.302 0.296 .310
.371 .054 .632
0.635 0.253 .013 0.105 0.048 .029 0.028 0.026 .274
0.004 0.023 .852 0.004 0.003 .198 0.000 0.002 .928
2.342 0.918 .012 0.426 0.143 .002 0.332 0.090 .000
.379 .820 .548
0.039 0.029 .183 0.002 0.004 .623 0.006 0.003 .035
0.018 0.027 .517 0.000 0.004 .930 0.003 0.003 .246
0.107 0.070 .125 0.012 0.009 .160 0.015 0.007 .038
4.790 2.609 .068 0.697 0.341 .041 0.542 0.261 .039
0.385 0.304 .206 0.012 0.040 .763 0.051 0.030 .096
0.367 0.206 .076 0.037 0.028 .181 0.051 0.020 .013
0.616 0.234 .009 0.078 0.035 .024 0.072 0.023 .002
6.171 4.948 .214 0.652 0.597 .275 0.866 0.494 .081
1.425 12.288 .908 16.679 1029.121 .987 0.398 1.231 .747
0.462 0.113 .000 0.096 0.028 .001 0.022 0.012 .068
0.405 0.092 .000 0.082 0.022 .000 0.019 0.010 .055
Apolipoprotein E; , regression coefficient; CPB, cardiopulmonary bypass;
xygenation; MDI, mental developmental index; NP, nasopharyngeal; PDI,
the great arteries with intact ventricular septum; TOF, tetralogy of Fallot;P
.376
.964
.110
.001
.006
.146
.144
.177
.000
.016
.000
.005
.169
.214
.397
.101
.914
.030
.388
.976
.474
.053
.021
.344
.457
.256
.121
.510
.005
.003
POE,
ane o
ion ofI.llele, lower NP temperature, and longer postoperative
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Dength of stay as significant predictors of a lower PDI score
Table 3). Black race was associated with higher score
he PDI. Lower birth weight, presence of a genetic syn-
rome, and the APOE 2 allele were predictors of lower
cores for both the MDI and PDI. The distribution of MDI
nd PDI scores for patients with one or more of these risk
actors compared with patients with no risk factor is shown
n Figure E1. Patients with very low scores on both the
nd PDI are more common in the group with at least one
isk factor. Overall, patient-specific factors (gender, ethnic-
ty, birth weight, birth head circumference, Apgar score at 1
inute, Apgar score at 5 minutes, genetic syndrome, APOE
enotype) explained more of the variability in the MDI
13.0% vs 5.3%) and the PDI (20.7% vs 7.6%) than did
ntraoperative factors (weight at surgery, cooling time,
HCA time, CPB time, lowest NP temperature, hemato-
rit). Inclusion of other variables did not improve the pre-
igure 1. Bar graph showing use and duration of DHCA. The
-axis is DHCA duration in 10-minute increments. The y-axis is
umber of patients. DHCA, deep hypothermic circulatory arrest.
igure 2. Bar graph showing distribution of MDI and PDI scores.
he x-axis is MDI/PDI score in 10-point increments. The y-axis is
umber of patients. In the general population, MDI and PDI scores
re normally distributed with a mean of 100 and a standard
eviation of 15. In this cohort, the distribution is shifted to the left,
ndicating worse performance. The PDI is more severely affected
han the MDI. MDI, Mental Developmental Index; PDI, Psychomo-por Developmental Index.
348 The Journal of Thoracic and Cardiovascular Surgery ● MaI
ictive accuracy of the models for either MDI or PDI. The
nal, and best, models (Tables 2 and 3) for both MD
DI accounted for less than 30% of the variance in the
cores, suggesting that unrecognized factors are important
eterminants of outcome.
Results of the neuromuscular examination were abnor-
al or suspect in 48 (26%) patients. The most common
bnormality on neuromuscular examination was hypotonia.
otential predictors of the neuromuscular examination are
isted in Table 1, as well as their univariate stati
ignificance. Stepwise logistic regression identified a model
ontaining lower birth weight, lower Apgar score at 1
inute, presence of a confirmed or suspected genetic syn-
rome, and longer postoperative length of stay as significant
redictors of an abnormal or suspect neuromuscular exam-
nation (Table 4). Black race and other race were si
antly associated with better performance on the neuromus-
ular examination.
Head circumference at 1 year was also assessed as a
urrogate for brain growth. The median head circumference
as 45.5 cm (range, 40.3–50.0 cm). Microcephaly (head
ircumference percentile  5%) was present in 44 (23%) of
88 patients. Potential predictors of the head circumference
t 1 year are listed in Table 1, as well as their uni
tatistical significance. Stepwise logistic regression identi-
ed a model containing male gender, head circumference at
irth, higher Apgar scores at 5 minutes, and higher lowest
P temperature as significant predictors of larger head
ABLE 2. Predictors of MDI (n  188)
Estimate SE t Pr(>|t|)
Intercept) 79.9084 5.4236 14.733 .0000
irth weight 0.0051 0.0016 3.212 .0016
resence of confirmed or
suspected genetic syndrome
6.0820 2.2634 2.687 .0079
POE 2 6.9136 3.1758 2.177 .0309
DI, Mental Developmental Index; SE, standard error; APOE, apolipopro-
ein E
ABLE 3. Predictors of PDI (n  188)
Estimate SE t Pr(>|t|)
Intercept) 51.1613 9.0248 5.6690 .0000
irth weight 0.0042 0.0018 2.3960 .0177
lack race 11.6915 3.6481 3.2050 .0016
resence of confirmed or
suspected genetic syndrome
8.0508 2.5063 3.2120 .0016
POE 2 8.9199 3.5954 2.4810 .0141
owest NP temperature 0.4802 0.2189 2.1930 .0297
ostoperative LOS 0.2521 0.1062 2.3730 .0188
DI, Psychomotor Developmental Index; SE, standard error; APOE, apoli-
oprotein E; NP, nasopharyngeal; LOS, length of stay.
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Dircumference at 1 year of age (Table 5). Vaginal del
as associated with a smaller head circumference at 1 year.
iscussion
he current study demonstrates that patient-specific factors
uch as birth weight, ethnicity, and the presence of a genetic
yndrome are important determinants of neurodevelopmen-
al outcome after neonatal and infant cardiac surgery. These
atient-specific factors explain considerably more of the
ariability in outcomes at 1 year of age than do intraoper-
tive management strategies, such as the use and duration of
HCA and hematocrit during CPB. In particular, neither the
se nor the duration of DHCA was associated with a worse
utcome at 1 year of age. However, the median duration of
HCA in the current study was 34 minutes (Figure 1
Overall scores for both the MDI and the PDI are lower
han population norms. Consistent with previous studies,
otor skills as assessed by the PDI and the neuromuscular
xamination are more significantly impaired after infant
ardiac surgery than is cognitive function assessed by the
DI.9-11 Interestingly, black infants performed better 
oth the PDI and neuromuscular examination than did in-
ants of other ethnic groups. This finding is consistent with
revious studies demonstrating that, among the general pop-
lation, scores for black infants on the PDI at 1 year of age
end to be higher than those for other ethnic groups.12,13 It
s worrisome that microcephaly, suggesting impairment of
rain growth, was identified in more than 20% of the cohort
t 1 year of age.
Many studies of neurodevelopmental outcome after car-
iac surgery have focused on intraoperative management
trategies.4,9-11 This focus is understandable inasmuch 
hese strategies can be modified and thus there is an oppor-
unity to potentially improve outcomes. On the basis of
hese studies, many surgeons have modified their intraop-
rative support techniques. However, review of these stud-
es suggests that the benefit of changing intraoperative sup-
ABLE 4. Predictors of abnormal or suspect neuromuscul-
ination (n  188)
Estimate SE t Pr(>|t|)
Intercept) 5.5013 1.9466 2.8260 .0047
irth weight 0.0011 0.0004 3.0120 .0026
PGAR at 1 min 0.3123 0.1177 2.6520 .0080
lack race 3.3821 1.3561 2.4940 .0126
ther race 1.8728 0.9440 1.9840 .0473
resence of confirmed
or suspected
genetic syndrome
1.5055 0.4419 3.4070 .007
ostoperative LOS 0.0772 0.0353 2.1880 .0287
E, Standard error; LOS, length of stay.ort techniques may be less than hoped. Indeed, the findings a
The Journal of Thoracicf previous studies, as well as the current study, are con-
istent with the hypothesis that factors (recognized and
nrecognized) other than intraoperative management strat-
gies are more important determinants of outcome and
xplain more of the variability in outcomes.
The neurologic status of children with CHD is often
bnormal at birth, before surgical intervention.4,14,15 There
s increasing evidence that in utero central nervous system
evelopment is often abnormal in children with CHD16
icrocephaly and congenital central nervous system mal-
ormations are common. Recent studies from our institution
ave demonstrated that cerebral blood flow is very low in
ome neonates with uncorrected CHD, often with evidence
f cerebral ischemia and preoperative white matter injury
haracterized by periventricular leukomalacia.17,18 New-
orn infants with CHD are also exposed to the potential
isks of hypoxia, acidosis, and hypotension. Low birth
eight is an important predictor of worse outcome. Many
actors may contribute to low birth weight, including 
aturity, associated genetic syndromes, placental insuffi-
iency, and intrauterine growth restriction, all of which may
ncrease the risk of neurodevelopmental delay.
In addition, genetic factors are a major determinant of
eurologic outcome in children with CHD. Many defects
re part of well-described syndromes with associated devel-
pmental dysfunction, independent of the cardiac defect or
ardiac surgery. APOE is an important regulator of choles-
erol metabolism.6,7 APOE-containing lipoproteins are th
rimary lipid transport vehicles in the central nervous sys-
em. There is increasing evidence that APOE is important
or neuronal repair. There are three common isoforms of
POE (E2, E3, and E4), which are encoded by three alleles
2, 3, and 4, respectively) and vary by single amino acid
ubstitutions. A strong association has been validated be-
ween the APOE 4 allele and Alzheimer disease. APOE
enotype has been shown to have an important role as a
eterminant of neurologic recovery after central nervous
ystem ischemia, intracerebral hemorrhage, and traumatic
rain injury. There is evidence of an association of APOE
enotype with neurocognitive decline after cardiac surgery
n adults and children.6,7 The finding that the APOE 2
ABLE 5. Predictors of head circumference (n  188)
Estimate SE t Pr(>|t|)
Intercept) 29.1072 1.8581 15.6650 .0000
ale gender 1.0262 0.2056 4.9910 .0000
aginal delivery 0.6738 0.2201 3.0610 .0026
irth head circumference 0.3560 0.0465 7.6550 .0000
PGAR at 5 min 0.2300 0.1149 2.0020 .0468
owest NP temperature 0.0772 0.0353 2.1880 .0287
E, Standard error; NP, nasopharyngeal.llele is associated with a worse outcome is consistent with
and Cardiovascular Surgery ● Volume 133, Number 5 1349
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1
CH
Dhe hypothesis that genetic variants that do not cause CHD
ay alter the response to environmental factors and thus
ncrease susceptibility to neurologic injury.
Well-designed trials assessing the impact of changes in
ntraoperative management strategies have often provided
onflicting data. In the BCAS, assignment to DHCA was
ssociated with an increased incidence of seizures in the
arly postoperative period.4 Evaluation at 1 year of a
emonstrated that the children assigned to DHCA had lower
DI scores.1 At 4 years of age, assignment to DHCA 
ssociated with impaired gross and fine motor skills, as well
s speech apraxia.2 However, cognitive function assesse
y full scale, verbal, and performance IQ was significantly
ower for the entire cohort compared with the general pop-
lation, and there was no treatment group effect. Social
lass predicted a larger percentage of the variation in IQ
24%) than did treatment group (DHCA vs low-flow CPB)
ssignment (3%). Similarly, at the 8-year evaluation, per-
ormance of the cohort for many neurodevelopmental do-
ains was worse than population norms, with no effect of
reatment group assignment.3 However, there were trea-
ent group–specific effects. Motor and speech skills were
ower in patients assigned to DHCA, whereas the low-flow
ypass group demonstrated worse scores for impulsivity
nd behavior. As at the 4-year evaluation, social class
23.7%) and VSD status (3.2%) explained more of the
ariance in IQ than did treatment group (DHCA vs low-flow
PB) assignment (0.3%). Treatment assignment resulted in
ifferent neurologic morbidities, rather than reducing their
requency or severity.
As part of a subsequent, prospective, randomized study
nvestigating blood gas management strategies (alpha-stat
s pH-stat) during CPB, investigators at Boston Children’s
ospital evaluated neurodevelopmental outcomes at 1 year
ge.10 The investigators concluded that neither strategy w
onsistently associated with improved or impaired out-
omes. PDI scores did not differ between treatment groups.
nterestingly, the effect of the blood gas management strat-
gy on MDI scores varied between subgroups on the basis
f the cardiac diagnosis. Patients with TGA and TOF tended
o have higher MDI scores when randomized to a pH-stat
trategy, but the differences were not significant. In the
SD subgroup, patients assigned to an alpha-stat strategy
ad significantly higher MDI scores than did those assigned
o a pH-stat strategy. This variation suggests that the inter-
ction of patient-specific factors (diagnosis) and intraoper-
tive management strategies may modulate outcomes.
A subsequent study evaluated hemodilution during CPB
s a potential risk factor for worse neurodevelopmental
utcome.11 Infants were randomly assigned to a target -
atocrit value of 20% or 30%. At 1 year of age, MDI scores
ere similar between groups. Significant predictors of MDIcore were gender, birth weight, and social class. Assign- t
350 The Journal of Thoracic and Cardiovascular Surgery ● Maent to the lower hematocrit group was the strongest single
redictor of lower PDI scores and accounted for 6.3% of the
ariance in PDI scores. However, other patient-specific fac-
ors were also independent predictors of PDI scores, includ-
ng preoperative endotracheal intubation, birth weight, and
ocial class. No other intraoperative management variable,
ncluding use and duration of DHCA, was predictive of a
orse outcome. Thus, as in the current study, patient-spe-
ific factors were important determinants of neurodevelop-
ental outcomes.
In the current study, as in the BCAS, longer postopera-
ive length of stay was an independent predictor of worse
eurodevelopmental outcome.5 There is increasing evidenc
hat postoperative events result in central nervous system
njury. In a previous study, we evaluated the incidence of
eriventricular leukomalacia early after neonatal and infant
ardiac surgery. Periventricular leukomalacia was identified
y early postoperative brain magnetic resonance imaging in
ore than 50% of neonates compared with 4% in patients
lder than 30 days at the time of surgery.19 Hypoxemia and
ypotension in the first 48 hours after surgery were associ-
ted with an increased occurrence of periventricular leu-
omalacia. Longer total support time was associated with
ncreased occurrence of periventricular leukomalacia, but
ot use or duration of DHCA.
imitations
his study is a single-center, secondary analysis of a sub-
roup of an observational study evaluating APOE genotype
s a risk factor for worse neurodevelopmental outcomes
fter infant cardiac surgery. It was not designed as a treat-
ent trial and may be underpowered to determine differ-
nces in outcome resulting from changes in intraoperative
anagement strategies, such as hematocrit and DHCA. The
atient population is heterogeneous and includes patients
ith many characteristics, such as genetic anomalies, which
ay confound attempts to elucidate the impact of intraop-
rative management strategies. The study group was limited
o 2-ventricle CHD repaired in one operation, intending to
inimize the effects of chronic cyanosis and multiple op-
rations. Many previous studies have attempted to further
inimize confounders by limiting eligibility to a few car-
iac defects and excluding low birth weight patients and
hose with significant extracardiac anomalies. Although this
pproach may enhance the ability to assess the impact of
hanges in management, it also significantly limits the gen-
ralizability of the findings to the larger population of
nfants with CHD. The current study is more diverse, in
erms of gender, ethnicity, and cardiac diagnosis, than some
revious studies. However, because of the exclusion of
hildren with some forms of complex CHD (single ventri-
le) and those undergoing multiple operations, the results of
he current study also may not be generalizable to the larger
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CH
Dopulation of patients with CHD. In addition, the intraop-
rative management strategies were not standardized. Fi-
ally, the predictive value of neurodevelopmental testing at
 year is limited.20 The full extent of an early injury ofte
ot completely recognized until long after the event, when
omplex cognitive and higher executive skills are required.
he larger APOE cohort is currently undergoing detailed
eurodevelopmental assessment at 4 years of age.
onclusions
n this large, heterogeneous cohort of patients undergoing
epair of 2-ventricle CHD, patient-specific factors are im-
ortant determinants of neurodevelopmental outcomes at 1
ear of age and contribute more substantially to the risk of
dverse neurodevelopmental outcomes than do intraopera-
ive management strategies. Consistent with previous stud-
es, intraoperative management strategies explain only a
mall portion of the variability in outcomes. Previously
escribed risk factors (both patient-specific and intraopera-
ive variables) explain only part (30%) of the variability in
eurodevelopmental outcomes, suggesting that unrecognized
actors are important determinants of outcome. Genetic factors
re a major determinant of neurologic outcome in children with
HD. Future studies of neurologic outcome and neuroprotec-
ive strategies must include risk-stratification for genetic and
ther patient factors that may alter the risk of central nervous
ystem injury and adverse neurologic outcomes. These factors
ay be more important determinants of outcome than are
ntraoperative management strategies. To improve neurodevel-
pmental outcomes for children with CHD, we must identify
nd understand the biologic pathways underlying interindi-
idual variation in outcomes and develop individualized, tar-
eted therapeutic strategies.
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iscussion
r Richard A. Jonas (Washington, DC). I congratulate you and
our colleagues for providing some data that will help us to
nravel the specific impact of patient-related factors on neurode-
elopmental outcome before general cardiac surgery.
What you have done is to perform a meta-analysis of a pro-
pective but nonrandomized study of the impact of a specific
enotype on neurodevelopmental outcome. Not surprisingly, you
ound that patient-specific factors were more important than intra-
perative manipulations such as the use of circulatory arrest,
ematocrit, or pH strategy.
I say “not surprisingly” because, as you yourself have pointed
ut in the limitations of the study, this is a very heterogeneous
atient population. For example, unlike previous work in this area,
ou included low birth weight patients and you included patients
ith known genetic factors and confirmed what is widely known,hat both of these factors have an important impact on outcome.
and Cardiovascular Surgery ● Volume 133, Number 5 1351
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1
CH
DIn addition, you made no attempt in your study to subject
atients to a uniform bypass strategy. The duration of cooling
efore circulatory arrest in some patients was as short as 5 minutes,
nd the lowest NP temperature recorded before circulatory arrest
as as high as 28°C.
I am concerned that the subliminal message that comes through
s that since patient-related factors are so important, we really do
ot need to focus any attention on remediable intraoperative fac-
ors.
Surely you would agree that studies that have attempted to
nroll only a very homogeneous patient population and then have
ubjected patients to a carefully controlled set of intraoperative
onditions with variation of only one factor, such as hematocrit or
H, are far more likely to produce specific information regarding
he relative importance of intraoperative factors, and the conclu-
ions derived from such studies should be interpreted in that light.
My first question for you is to ask you, once again, why you
ontinue to use the alpha-stat strategy in patients in whom you are
onsidering using circulatory arrest despite the fact that a prospec-
ive, randomized trial of pH strategy documented a significantly
igher incidence of perioperative complications, including death to
P value of .06, when the alpha-stat strategy was used.
I am also interested to know your current strategy regarding
ematocrit in patients in whom you intend to use DHCA. What do
ou consider the current limits of a reasonable standard of care? As
e get asked regularly by the lawyers, what is a reasonable
tandard of care currently for the application of DHCA in terms of
uration of cooling, minimum temperature for circulatory arrest,
nd maximal duration?
Finally, I am interested to know what you believe the next step
ill be, more specifically, in identifying and understanding the
iologic pathways that underlie individual variation in outcomes
nd how you plan to move to developing individualized targeted
herapeutic strategies which, I agree, is certainly going to be a very
mportant development that is coming out of this important work
hat you are doing.
I certainly do not want to downplay the importance of your
ocus on patient-specific factors. These clearly are important fac-
ors, as we demonstrated in the circulatory arrest study. But I do
ot think you should use the presence of important patient-specific
actors to downplay the fact that there may be differences in
utcome according to intraoperative strategies.
Dr Gaynor. First, I think it is important to recognize that even
hough this is a prospective observational study in which manage-
ent strategies were not stratified, the findings are very consistent
ith the other studies such as you mentioned, the hematocrit study,
he blood gas study, and the circulatory arrest study. The amount
f variability explained by DHCA is very consistent.
In your study of hematocrit, although hematocrit was the single
ost important factor, you also found that birth weight (even
hough you excluded low birth weight infants), preoperative intu-
ation, and other factors were significantly important determinants
f outcome.
In discussing the alpha-stat versus pH strategy, there were some
erioperative differences in outcome. However, as you acknowl-
dged, neither strategy was associated with improved or impaired
eurodevelopmental outcomes. a
352 The Journal of Thoracic and Cardiovascular Surgery ● MaI pulled out the subgroup of patients who met the criteria for
ntering the hematocrit study—no genetic syndromes, 2-ventricle
eart disease, birth weight greater than 2.3 kg—and looked at the
DI and PDI for ours with an alpha-stat versus pH stat. The mean
DI for your group was 85.6 and ours was 85.5 for similar patients.
he mean MDI for yours was, I think, 93-point something and ours
as 94. Thus I think the outcomes are very similar, even though
e used an alpha-stat and you used a pH-stat strategy, when the
atient populations are comparable.
In terms of the cooling for DHCA, there was one patient who
ad a 1-minute period of circulatory arrest at 28°C. Everybody else
as cooled for at least 15 minutes, and I believe the median was
little bit greater than that. That one patient is an outlier. We do,
ndeed, cool at least 15 to 20 minutes before the use of circulatory
rrest. We have gone to a higher hematocrit on hemodilution. We
sually maintain a hematocrit level around 30% during hemodilu-
ion now when we are going to use DHCA.
I think the best data currently out there for duration are the
CAS data, which suggest a safe duration somewhere, with the
trategies from the late 1980s, of around 40 minutes. I do not
ropose that these data will tell us whether there is a safe duration
r not.
In the alpha-stat study and in the hematocrit study, approxi-
ately 40% of the patients had circulatory arrest. And circulatory
rrest was not a risk factor for outcome in either one of those
tudies. So I wonder how much effect circulatory arrest has on
utcome.
What I think is important is that these studies have provided an
ncredible amount of information, but I do not know how much
ariability, how much more improvement in outcome, we are going
o get by changing the factors and applying them to the whole
opulation. I think there is good evidence that there are genetic
actors that affect the severity—the inflammatory response, coag-
lation profiles, tolerance to ischemia—which vary significantly
cross patient populations.
As we begin to understand, we may be able to identify high-risk
ubgroups, for example, a child who is at a high risk for a
yperinflammatory response or a child who is at risk for micro-
ascular coagulation. I do not know where the factors are going to
e. I think we are going to need a genetic association study in
uch more detail than what I have done with one specific allele.
owever, if we can identify genetic syndromes and biologic path-
ays that have relevance to the mechanism of injury, then perhaps
f a child produces a lot of tumor necrosis factor-, there may be
monoclonal antibody against tumor necrosis factor- that will be
mportant for him. If the child is at risk for microvascular coagu-
ation, perhaps we need another type of anticoagulation. I do not
now, but I think that is the direction.
What I hope to do with this paper is to say that we need to focus
n some of these other factors because I think the amount we are
ble to change the outcomes with our intraoperative strategies may
e limited. It is a testable hypothesis. We have to find out.
Dr Jonas. Regarding the specific changes that you might make,
epending on genetic subtype, patients at risk, what exactly would
e done?
Dr Gaynor. Well, I think you would have to define. There are
ome studies in patients with sepsis. If you have identified that they
re at risk for a hyperinflammatory response, there are specific
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Deceptor blockers that can be used to treat them. If we can identify
hese patients preoperatively, perhaps we should attempt to blunt
he inflammatory pathway in that subgroup of patients.
I do not have the specific treatment strategies yet, but I think
hat is a focus that, as we go forward, we should begin to look at.
ow are these patients different? One of the things that I found
triking in this was the tremendous variability in outcome in the
hildren who had continuous bypass. Even when we eliminated the
enetic syndrome patients, we still found the same patient factors
utweighed the variability of the operative factors.
Dr John E. Connolly (Irvine, Calif). I congratulate the authors
n their interesting findings as likely causes of poor neurodevel-
pment outcomes. I have several questions.
How did you monitor the infant’s temperature and how did you
ecide how long to cool to obtain what you thought was a safe
egree of brain cooling? Did you use ice around the head of the
atient?
We have also been interested in the possible causes of supra-
entorial damage from profound hypothermia and circulatory ar-
est. To study that, we subjected 80 dogs of various ages to the
echnique after our psychology department had conditioned them
o perform complicated tasks to be repeated after recovery from
he hypothermia and arrest. We used direct brain temperatures on
hose dogs.
We first used deep hypothermia and arrest for open neurosur-
ical vascular procedures in which we could directly monitor the
rain with a thermistor probe in the cortex. We were very im-
ressed with the significant lag between the brain temperature and
he body temperature during cooling. Our conclusions from that
tudy were that a brain temperature of 20°C is safe for 60 minutes
f arrest, but it requires 60 minutes of cooling to reach. For 30
inutes of arrest, we found that we needed 30 minutes of cooling
or the brain temperature to reach 28°C. Our recommendation is
hat it is always better to cool too long than too short a period of
ime before arrest.
Dr Gaynor. We used NP temperature as our surrogate for brain
emperature. All patients but one were cooled at least 15 minutes
o an NP temperature of 18°C, and we used topical hypothermia to
he brain by packing the head in ice.
Dr Connolly. And how long did you cool, just 30 minutes?
Dr Gaynor. At least 15 minutes in all but one patient.
Dr Connolly. Before we had conditioned our dogs, many of the
ogs would seem all right and could run around, but this did not
emonstrate any damage supratentorially. Therefore, we needed to
rain the dogs to do some fancy tricks, and then we could assume
hat there had been absolutely no change in the brain. That is when
e concluded that 30 minutes was probably the minimum. t
The Journal of ThoracicDr Bradley S. Allen (Houston, Tex). As Dr Fraser and Dr
anley said yesterday, and Dr Jonas alluded to today, the devil
ometimes is in the details. I have two questions.
First, what pressure or flow did you use for your continuous
ypass patients? Moreover, did you monitor the pressure, as too
igh or too low a pressure may be detrimental?
Second, since you saw marked variability in the continuous
rofusion group, did you look at multiple variables, as Dr Jonas
ecommended (ie, hematocrit, pressure, flow) to determine
hether any of those variables explained the variability in this
roup?
Dr Gaynor. The pump strategies were not standardized. The
ump flow was at the discretion of the surgeon.
We did look at duration of cooling, lowest temperature, and
ematocrit. Although I think those are potentially important vari-
bles, I do not know of any data that correlate a certain flow or a
ertain perfusion pressure during continuous bypass to indicate
hat one pressure or one flow rate is better than another in a human
ith long-term neurodevelopmental outcome. I do think that is
omething that could be tested and standardized. It is a testable
ypothesis and those studies need to be done.
Dr Tara Karamlou (Toronto, Ontario, Canada). Did you look
t socioeconomic status? Did you look at a Hollingshead scale, or
ow important is that?
Dr Gaynor. We did look at a Hollingshead scale. It did not
ome out in the analysis, but I think there are some other studies
hat suggest that at 1 year the environmental influences may not be
uite as great. We are now evaluating these children at 4 years, and
will bet the Hollingshead scale will be a significant predictor at
years. However, we did include that in the analysis.
Dr Christo I. Tchervenkov (Montreal, Quebec, Canada). It
id not come up in the discussion, but what was the preoperative
tatus of the patient? We have shown that 60% of neonates and
0% of infants who have undergone a careful examination by a
eurologist and neuropsychologist are abnormal preoperatively.
erhaps some of the variability in outcome could be explained by
he preoperative neurologic status of these patients. Have you done
ny preoperative assessments?
Dr Gaynor. I agree entirely. There was not a formal preoper-
tive status, but I think the fact that lower birth weight Apgar
cores were associated with the worst outcome suggests that pre-
perative factors are an important determinant of outcome. Again,
ack to our hypothesis, it is patient factors, things that exist before
nd after the operation, as much as or more than what happens in
he operating room.
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DFigure E1. A, X-Y plot showing MDI and PDI scores for 111 patients with no risk factors (low birth weight, genetic
syndrome, or APOE 2 allele). The x-axis is the MDI score and the y-axis is the PDI score. B, X-Y plot showing MDI
and PDI scores for 77 patients with one or more risk factors (low birth weight, genetic syndrome, or APOE 2
allele). The x-axis is the MDI score and the y-axis is the PDI score. The number of patient with low scores on both
measures is increased compared with patients with no risk factors (A). BW, Birth weight; APOE, apolipoprotein
E; MDI, Mental Developmental Index; PDI, Psychomotor Developmental Index.353.e1 The Journal of Thoracic and Cardiovascular Surgery ● May 2007
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DABLE E1. Preoperative and intraoperative characteristics of the patients who returned and of those who did not return
ariable
Patients evaluated at 1 year Patients who did not return
Stat PSample n Mean (%) SD Sample n Mean (%) SD
ender 188 55 2.229 .135
Female 85 45.2% 18 32.7%
Male 103 54.8% 37 67.3%
thnicity 188 55 1 2.364 .669
White 136 72.3% 35 63.6%
Asian/Pacific Islander 4 2.1% 1 1.8%
Black 23 12.2% 11 20.0%
Hispanic 6 3.2% 2 3.6%
American Indian 0 0.0% 0 0.0%
Other 19 10.1% 6 10.9%
POE genotype 188 55 2.168 .826
APOE 22/23 22 11.7% 9 16.4%
APOE 33 117 62.2% 33 60.0%
APOE 33/44 42 22.3% 10 18.2%
APOE 24 5 2.7% 1 1.8%
Unknown 2 1.1% 2 3.6%
iagnosis 188 55 5 6.417 .093
TGA/IVS 39 20.7% 5 9.1%
VSD 34 18.1% 15 27.3%
TOF 56 29.8% 21 38.2%
Other 59 31.4% 14 25.5%
irth history
Type of delivery 186 48
Cesarean section 129 69.4% 31 64.6% 0.211 .646
Vaginal 57 30.6% 17 35.4%
Multiple gestation 187 47
Yes 10 5.3% 0 0.0% 74.397 .000
No 177 94.7% 47 100%
Gestational age (wk) 188 38.40 2.44 49 38.63 2.27 0.632 .529
APGAR 1 min 184 7.72 1.65 46 7.93 1.36 0.906 .368
APGAR 5 min 184 8.63 0.94 46 8.76 0.71 1.043 .300
Birth weight (g) 187 3107 667 50 3128 630 0.213 .832
Birth length (cm) 182 49.41 3.73 46 49.03 3.39 0.676 .501
Birth head circumference (cm) 183 33.47 2.18 46 33.04 2.26 1.161 .250
reoperative variables
Intubation 186 48
Yes 45 24.2% 10 20.8% 0.089 .765
No 141 75.8% 38 79.2%
Prostaglandin infusion 186 48
Yes 51 27.4% 9 18.8% 1.084 .298
No 135 72.4% 39 81.2%
reoperative LOS (d) 188 2.15 4.92 55 1.49 2.09 1.454 .147
perative variables
Age at operation (d) 188 61.34 54.59 55 80.33 61.02 2.078 .041
Weight at operation (kg) 188 4.26 1.35 55 4.39 1.30 0.641 .523
Total support time (min) 188 86.99 43.47 55 73.85 28.07 2.660 .009
CPB duration (min) 188 75.32 46.63 55 63.58 29.61 2.239 .027
Use of DHCA 188 55 0.546 .460
Yes 67 35.6% 16 29.1%
No 121 64.4% 39 70.1%
DHCA duration (min) 67 32.7 14.8 16 35.3 10.3 0.819 .419
Cooling time (min) 188 12.40 6.09 55 12.58 7.07 0.174 .862
Lowest NP temperature (°C) 188 22.80 5.30 55 23.93 5.02 1.442 .153
Hematocrit after hemodilution (%) 188 27.22 4.15 55 27.53 3.98 0.502 .617
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DABLE E1. Continued
ariable
Patients evaluated at 1 year Patients who did not return
Stat PSample n Mean (%) SD Sample n Mean (%) SD
ECMO/VAD 188 55
Yes 2 1.1% 0 0.0% 104.292 .000
No 186 98.9% 55 100%
Delayed sternal closure 188 55 70.719 .000
Yes 13 6.9% 0 0.0%
No 175 93.1% 55 100%
ostoperative variables
Total hospital LOS (d) 188 10.91 13.02 55 8.40 6.77 1.909 .058
Postoperative LOS (d) 188 8.76 10.73 55 6.91 5.56 1.708 .089
POE, Apolipoprotein E; TGA/IVS, transposition of the great arteries with intact ventricular septum; VSD, ventricular septal defect; TOF, tetralogy of Fallot;
OS, length of stay; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; Total support time, CPB time  DHCA time; NP,
asopharyngeal; ECMO, extracorporeal membrane oxygenation; VAD, ventricular assist device.
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